Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
Xiong Y, Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Wang J, Chang Y, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Bai Q, Guo J, Xu J. Xiong Y, et al. Among authors: zeng h. J Immunother Cancer. 2020 Mar;8(1):e000447. doi: 10.1136/jitc-2019-000447. J Immunother Cancer. 2020. PMID: 32217761 Free PMC article.
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Qi Y, Xia Y, Lin Z, Qu Y, Qi Y, Chen Y, Zhou Q, Zeng H, Wang J, Chang Y, Bai Q, Wang Y, Zhu Y, Xu L, Chen L, Kong Y, Zhang W, Dai B, Liu L, Guo J, Xu J. Qi Y, et al. Among authors: zeng h. Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306075 Free PMC article.
Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Zhu Y, Xu L, Dai B, Liu L, Guo J, Xu J. Wang Z, et al. Among authors: zeng h. Oncoimmunology. 2020 Apr 10;9(1):1747332. doi: 10.1080/2162402X.2020.1747332. eCollection 2020. Oncoimmunology. 2020. PMID: 32313725 Free PMC article.
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T, Zhou Q, Zeng H, Zhang H, Liu Z, Shao J, Wang Z, Xiong Y, Wang J, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Chang Y, Wang X, Xu J. Wang T, et al. Among authors: zeng h. Cancer Immunol Immunother. 2020 Sep;69(9):1855-1867. doi: 10.1007/s00262-020-02583-y. Epub 2020 May 4. Cancer Immunol Immunother. 2020. PMID: 32367308 Free PMC article.
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Zhou Q, Qi Y, Wang Z, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Xu L, Dai B, Guo J, Zhu Y, Zhang W, Xu J. Zhou Q, et al. Among authors: zeng h. J Immunother Cancer. 2020 Apr;8(1):e000228. doi: 10.1136/jitc-2019-000228. J Immunother Cancer. 2020. PMID: 32371459 Free PMC article.
8,008 results